Clinical trial
Real-World Efficacy and Safety of Daridorexant in Chinese Patients With Insomnia (DREAM-Real): A Multicenter, Prospective Observational Study
NCT07847021 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-World Efficacy and Safety of Daridorexant in Chinese Patients With Insomnia (DREAM-Real): A Multicenter, Prospective Observational Study
- Lead sponsor
- Shanghai Mental Health Center
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- July 31, 2028
- Enrollment
- 500 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
insomnia